PPT-The Global Pharmaceutical Industry

Sabena Ahmad Iveta Smincakova Dawn Bradbury Porters Five F orces F ramework Johnson et al 2006 Exploring Corporate Strategy 7 th Ed Essex Pearson Education Limited p80. . BY. Dr. RAJESH KUMAR SINGH. Associate Professor. Delhi Technological University (DCE), Delhi. . 1. Plan of Presentation. Introduction of Pharmaceutical Industry. Quality . and . Environmental Requirements. Expectations from European industry . regarding . collaboration on drug quality and environment. A Global industry acts with global standards. 2. Excellence Builds on Continual Improvement. version. . : . 21/09/. 2015. Growth and competitiveness of the pharmaceutical industry. www.efpia.eu. Growth & Competitiveness. Growth and competiveness - rationale. Why is the pharmaceutical industry a key asset to European competitiveness ? . version. . : . 21/09/. 2015. Growth and competitiveness of the pharmaceutical industry. www.efpia.eu. Growth & Competitiveness. Growth and competiveness - rationale. Why is the pharmaceutical industry a key asset to European competitiveness ? . GlaxoSmithKline. Health matters in a globalising world. TNCs – Transnational Corporations are companies that operate in at least two countries (and often many more).. Headquarters and research facilities tend to be located in MEDCs whilst manufacturing plants have increasingly been located in LEDCs to take advantage of cheaper labour costs. . The Brookings Institution • . Washington, DC. Monday, October 19. th. , 2015. Promoting the Adoption of . Advanced . Manufacturing in the Pharmaceutical Industry: the FDA . Perspective. . Promoting Continuous Manufacturing in the Pharmaceutical Sector. Presented by:. Nathan . Funk, MHA, BS. Environmental Health & Safety Officer. WakeMed Health & Hospitals. 3000 New Bern Avenue. Raleigh, NC 27610. (919) 350-8375 Office. WakeMed.org. Objectives. Compliance Assurance. Northeast District. November 17, 2015. Why Should I Care About Pharmaceutical Waste?. Hazardous waste pharmaceuticals disposed of improperly:. May contaminate soil or seep into groundwater contaminating drinking water supply. T.U. . Federation of Chemical, Glass and Ceramic. . Industries. . in Poland.. Józef Woźny- . President. National . Pharmaceutical Industry plays an important role in the Polish health & care system provides patients with affordable medicines available to treat most illnesses. . B. enefit Management” or “Pharmacy . Benefit Management” . is the set of rules, controls and enforcement tools that define how eligible beneficiaries can obtain third party payment for prescription medicines under a public budget or insurance funded healthcare program. sector. . Cécile . Macé. Department of Essential Medicines and Health Products. English Technical Briefing Seminar. 30 October 2013. Ten leading causes of inefficiency. World Health Report 2010, Chapter 4. INGREDIENTS AND EXCIPIENTS DEFINITIONS . AND . TYPES. Lec. Dr . Athmar. . Dhahir. . habeeb. PhD in industrial pharmacy and pharmaceutical formulations . To . produce a drug substance in a . final dosage . Industry Introduction. Challenges & Opportunities. Industry Introduction. 2010 China’s Health Expenditure was 5.1% of the GDP. From WHO statistic yearbook and . Tengwei. 2013 semiannual summit. Denis Kibira, PhD. National Coordinator . MeTA. -Uganda. CEO- DUMAIC Global Health. About . MeTA. & DUMAIC. MeTA. is a multi-stakeholder platform to improve access to health commodities.. We are a catalyst/driver for change..